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This paper formed part of a series of background papers prepared for the ICRIER
India  Health  Study,  “Changing  the  Indian  Health  System:  Current  Issues,  Future
Directions” by Rajiv L. Misra, Rachel Chatterjee, and Sujatha Rao. The India Health
Study,  prepared  under  the  team  leadership  of  Rajiv  Misra,  former  Health  Secretary,
Government of India, was funded by the Bill and Melinda Gates Foundation.
Among the major health transitions witnessed in the second half of the twentieth
century,  the  most  globally  pervasive  change  has  been  the  rising  burden  of  non-
communicable diseases (NCDs). This has given rise to new challenges of providing acute
and chronic care for NCDs, especially in poor countries such as India with an already
existing mismatch between health care needs and resources. This paper  examines the
socio-economic  impact  and  burden  of  NCDs  and  discusses  various  strategies  for  the
prevention  and  control  of  such  diseases  in  India.  It  recommends  that  existing  health
systems  will  need  to  be  reorganized  and  reoriented  to  include  the  prevention,
surveillance, and management of NCDs. The paper also recommends that evidence based
clinical practice and appropriate use of technologies should be promoted at all levels of
health care, including tertiary services.
The prevention and control of NCDs poses a major public health challenge for the
country  in  the  twenty-first  century.  I  am  very  pleased  that  ICRIER  has  had  the
opportunity  to  participate  in  the  debate  in  this  area.  This  contribution  by  K.  Srinath
Reddy will help significantly in providing a better focus to the problems and solutions at
hand.
Arvind Virmani




The second half of the twentieth century witnessed major health transitions in the
world, propelled by socio-economic and technological changes which profoundly altered
life expectancy and ways of living while creating an unprecedented human capacity to
use science to both prolong and enhance life. Among these health transitions, the most
globally  pervasive  change  has  been  the  rising  burden  of  non-communicable  diseases
(NCDs).  Epidemics  of  non-communicable  diseases  (NCD)  are  presently  emerging  or
accelerating in most developing countries (Murray and Lopez 1996).  Even as infections
and nutritional deficiencies are receding as leading contributors to death and disability,
cardiovascular diseases (CVDs), cancers, diabetes, neuropsychiatric ailments, and other
chronic diseases are becoming major  contributors to the burden  of  disease.  India  too
illustrates this health transition, which positions NCDs as a major public health challenge
of growing magnitude in the twenty-first century.
As India experiences a rapid health transition, the mismatch between health care
needs and resources is widened by  an expanded list of health conditions that vie for
attention from policy-makers and public health action while posting competing claims for
clinical care.  The complexities are compounded when policy has to prioritise on the
basis of disease burdens, cost-effectiveness, and equity while the delivery systems have
to simultaneously cope with the transformative pressures of economic restructuring and
health care reforms. The challenges of providing acute and chronic care for NCDs in such
settings  are  immense,  yet  the  imperatives  of  proper  planning  and  performance  for
delivering such care become increasingly urgent as health transition rapidly rewrites a
new agenda for health care in the India.
Existing  health  systems  need  to  be  reorganised,  reoriented,  and  recruited  to
deliver the expanded mandate of health care involving the prevention, surveillance and
management  of  chronic  diseases.  The  sustained  nature  of  preventive  interventions,
required over many years, as well as the growing demand for acute and chronic care of
NCDs will need to be accommodated into the agenda of primary and secondary health2
care. Surveillance of NCDs and their risk factors should also become an integral function
of health systems, complementary to the other surveillance functions they are currently
performing. Evidence based clinical practice and appropriate use of technologies should
be promoted at all levels of health care, including tertiary services.
Determinants of Health Transition
Health transition, whereby NCDs become the dominant contributor to the burden
of disease, is principally due to a combination of demographic and lifestyle changes that
result from socio-economic development. Demographic transition is characterised by a
decline  in  mortality,  followed  by  a  drop  in  fertility.  During  this  transition,  the  age
structure of the population changes from a pyramidical shape to a more columnar shape,
as fertility declines and the population ages. This is then reflected in the profile of the
causes of death. As industrialisation and urbanisation occur, there is a decline in  the
mortality  attributable  to  infectious  diseases  and  nutritional  disorders.    As  more
individuals survive to enter the middle ages, the years of exposure to the risk factors of
chronic  disease  increase.  Simultaneously,  urbanisation,  industrialisation,  and
globalisation are often  accompanied by  several  undesirable  lifestyle  alterations in  the
form of a diet rich in saturated fat, salt, and excess calories, decreased physical activity,
addictions like tobacco and alcohol, and augmentation of psychosocial stress. Thus the
dose  and  duration  of  risk  factor  exposure  both  increase,  resulting  in  large  numbers
manifesting  lifestyle  related  diseases  and  their  consequences.  Health  transition  is
characterised  by  a  demographic  transition  in  the  age  profile  and  an  epidemiologic
transition marked by the shift in the cause of death profile with the increasing dominance
of NCDs (Omran 1971; Olshansky and Ault 1986).
In addition, recent evidence suggests that impaired foetal nutrition, reflected in
small  birth  size,  results  in  programmed  susceptibility  adult  cardiovascular  disease,
diabetes, and some cancers. Migrant Indians have also been shown to have excess rates of
coronary  heart  disease  (CHD)  and  diabetes  in  comparison  to  other  ethnic  groups,
indicating a magnified response to environmental change. These factors will adversely3
impact on the future burden of NCDs, as India experiences health transition (Reddy and
Yusuf 1998; Reddy 1999).
Socio-economic Impact of NCDs and Equity Issues
Death or disability from NCDs in the productive middle ages results in major
economic burdens on the affected individuals, their families, and society as a whole. The
management of established NCDs (diagnosis and therapy) is often technology-intensive
and expensive. Individual as well as societal resources are already being drained, at a
disproportionately high level, by the tertiary care management of NCDs, often drawing
scarce resources away from the unfinished agenda of infectious disease and nutritional
disorder control.
Though NCD epidemics usually originate in the upper socio-economic strata, they
diffuse across the social spectrum, with the social gradient ultimately reversing and the
poor  becoming  predominantly  afflicted.  Indeed,  in  the  more  mature  stages  of  these
epidemics, the poor are the often worst afflicted in terms of disease and usually the most
marginalised  in  terms  of  care.  This  historical  experience  of  the  developed  countries,
where the NCD epidemics matured over the past half-century, is likely to be replicated in
the developing countries in the coming half-century. There is recent evidence from some
Indian studies that the social gradient for CVDs has already begun to reverse in some
population  groups  in  India,  especially  in  1arge  urban  settings  (World  Bank  1999).
Tobacco consumption is also higher in rural as compared to urban populations and in the
poor as compared to the rich population groups. The future risk of tobacco-related NCDs
is, therefore, likely to be higher in these groups (Chadha et al. 1997; Reddy 1993). A
comparison of per capita income profile and death rates in Punjab, Maharashtra, Andhra
Pradesh,  and  Orissa  in  1988  reveals  that  as  per  capita  income  profile  progressively
declines from Punjab to Orissa, the probability of death between the ages of 15 and 60
years  progressively  rises  (19  per  cent,  27  per  cent,  34  per  cent,  and  38  per  cent
respectively). NCDs are a major contributor to deaths in this age group.4
These  post-transitional  diseases  also  have  macro  and  micro  economic  impacts
which may prolong the high burden of pre-transitional diseases in developing country
settings. The loss, due to death and disability, of productive persons in mid-life, cripples
development  and  perpetuates  social  conditions  which  foster  communicable  and
nutritional disorders. The loss of a wage earner in the family has devastating effects on
the  nutrition,  education,  and  health  care  access  of  other  family  members,  especially
young  dependents.  The  twin  agendas  of  health  care,  mandated  by  pre-and  post-
transitional  diseases,  are  not  competitively  exclusive  but  are  synergistically
complementary. The goal of extending health care benefits across an expanding lifespan
requires that these two agendas  be  harmonised  in  India,  as  we  brace  up  to  meet  the
challenges of health transition.
Much of these economic and health burdens could be obviated
(a)  in  the  short  term  by  strategies  which  involve  low-cost  screening  for  early
detection of NCDs in whom early interventions effectively alter the natural
history  of  disease  and  the  use  of  the  several  low  cost,  high  impact
interventions for secondary prevention and clinical care which are now readily
available and
(b)  in the long term by investment in population based prevention strategies for
preventing  the  acquisition  or  augmentation  of  risk  in  hitherto  low-risk
populations and reduction of risk in populations already affected by health
transition.
Burden of NCDs (Present and Projected)
Even at the present stage of health transition, India contributes substantially to the
global burden of NCDs. In 1990, India accounted for 19 per cent of all deaths, 16 per cent
of all NCD deaths, and 17 per cent of all CVD deaths in the world. CVDs in India alone
accounted for around 2.4 million deaths, in contrast to nearly 3.2 million deaths due to
that cause in all the industrialised countries together (Murray and Lopez 1996).5
While the present high burden of NCD deaths is itself an adequate reason for
public health attention, a greater cause for concern is the early age of these deaths in
India compared to the developed countries. More NCD deaths in India occur in middle-
age (35–69 years) than in industrialised countries, where they occur largely in old age
(>70 years). Even as the overall NCD burdens will rise sharply by 2020 (Tables I and II),
disproportionate loss of lives in mid-life will continue to constitute a major burden (Table
III). Table IV provides a comparison between India and established market economies
(EME). In India, 52.2 per cent of all CVD deaths in 1990 occurred before the age of 70
years, in contrast to 22.8 per cent in the EME countries (Murray and Lopez 1996; Reddy
and Yusuf 1998).
Table I
GBOD Estimates for India (1990, 2020)
India (1990)
Population = 850 million
India (2020)
Population = 1267 million





































Group I = Communicable, maternal, perinatal, and nutritional conditions
Group II = Non-communicable Disease
Group III = Injuries
DALY = Disability Adjusted Life Year
GBOD = Global Burden of Disease
Source: Murray and Lopez (1996).6
Table II
Contribution of NCDs and Injuries to Mortality in India (1990, 2020)
Cause of Death Cause-specific
Proportionate Mortality
(as % of total mortality)
1990 2020
Total NCD 40.4 66.7
Cardiovascular 24.2 41.8
Malignant neoplasm 5.4 11.4
Neuropsychiatric 1.1 0.9
Total Injuries 8.6 11.7
Unintentional 6.9 9.5
Intentional 1.6 2.2
Source: Murray and Lopez (1996).
Table III
Mid-life Mortality due to NCDs in India (1990, 2020)
Cause of Death Percentage of cause-specific mortality occurring in the
age group of 30–69 yrs
1990 2020
Total NCD 48.9 51.3
Cardiovascular 48.2 47.7
Malignant neoplasm 64.6 69.2
Neuropsychiatric 40.6 39.6
Total Injuries 36.3 52.8
Unintentional 34 52
Intentional 45 56.4
Source: Murray and Lopez (1996).
Table IV
Early Mortality due to NCDs in India (1990, 2020)
Age profile of NCD deaths
(% of NCD deaths in each range)








<30 yrs 12.2 3 4.1 0.6
30-69 yrs 48.9 23 51.3 24.8
>70 yrs 38.9 74 44.6 74.5
Source: Murray and Lopez (1996).7
The high prevalence of diabetes in urban and migrant Indians is also a cause for
concern. Urban estimates of diabetes in adults aged over 35 years are in the range of 16–
20 per cent, while the corresponding rural estimates are around 4 per cent. With such
rates, it has been estimated that India has the largest number of diabetics in the world. As
dietary habits worsen and physical activity decreases with resultant obesity, diabetes will
become  an  increasingly  frequent  contributor  to  NCD.  It  has  been  estimated  that  the
number of persons with diabetes will rise from 19.4 million in 1995 to 57.2 million in the
world, even as India leads the global table for the number of diabetes (King et al. 1998).
Since these estimates are based on older and higher cut-off values for the diagnosis of
diabetes and also do not take into account the category of impaired glucose tolerance, the
overall burdens of disease attributable to diabetic and pre-diabetics may be even higher
than those projected.
There will also be a sharp rise in disability adjusted life years (DALYs) lost due
to  NCDs  between  1990  and  2020.  This  is  illustrated  by  the  rise  in  the  DALY  loss
attributable to CVDs where India will be the global leader (Fig. 1).
Figure 1
Burden of CVDS, 1990–2020
IND=India; CHI=China; SSA=Sub Saharan Africa; MEC=Middle Eastern Cresent;
LAC=Latin American Countries; EME=Established Market Economies; FSE=Former
Socialist Economies; OAI=Other Asia and Islands.
Source: Murray and Lopez (1996).8
While  these  estimates  (present  and  projected)  are  based  on  a  variety  of  data
sources of limited coverage and uncertain validity, they are the best available estimates
from a globally acknowledged data source [the Global Burden of Disease (GBOD) study
by Murray and Lopez in 1996].  Some Indian investigators have questioned the estimates
for 1990, based on independent secondary analysis and modelling (Anand 2000). The
differences are not substantially large. While the precise dimensions of the epidemic may
be difficult to gauge at present, the directions of its growth are indisputable.
The prevalence/incidence of various NCDs for 1998 has also been estimated, for
India, based on various published studies from different regions (Anand 2000). These are
profiled in Table V. These estimates may be relatively conservative, as suggested by the
comparison with the diabetes prevalence estimates of the World Health Organization.
Even then, it is estimated that about one-fifth of the population would have at least one of
these selected NCDs.
Table V
Estimated Number of Cases of Selected NCDs in India, 1998
Disease Prevalence /
incidence
Number of cases % of total
population
All Cancers Prevalence 2 million 0.2
Heart diseases (IHD,
HT, Stroke, RHD)
Prevalence 65 million 6.6
Respiratory diseases Prevalence 65 million 6.6
Diabetes mellitus Prevalence 13 million 1.3
Injuries Incidence 7 million 0.70
Source: Anand (2000).
The  lag  period  between  exposure  to  risk  factors  of  NCDs  and  their  clinical
manifestations  make  current  mortality  rates  unsuitable  for  prospective  public  health
planning, since they only represent past exposures over some decades. The present levels
of risk factor exposure would be more meaningful in predicting future risk and driving
public  health  policy.  The  rising  levels  of  hypertension,  diabetes,  obesity,  tobacco
consumption, and blood lipids in Indian population groups have been well documented in9
recent years (Chadha et al. 1997; Reddy 1993; King et al. 1998; Anand 2000; Gupta et al.
1996).  These too portend a major rise in future NCD burdens in India.
Strategies
The principles of prevention which underline the strategies for NCD control are as
follows.
Principle 1:  Risk operates in a continuum—not across arbitrary thresholds; Risk
reduction benefits across the range.
Principle 2:  Majority of NCD events arise in a population from the middle of the
distribution (of a risk factor) than from its high end.
Principle 3:  Co-existence of risk factors leads to interactive risk which is
multiplicative.
Principle 4:  The  absolute  risk  of  a  major  NCD  event  (e.g.  CHD/stroke)  is
dependent on the overall risk profile contributed by co-existent risk
factors operating in a continuum.
Traditionally, public health approaches to NCD control have been (a) a high risk
strategy, targeting persons with high levels of risk factors and employing interventions to
reduce them, usually with drugs and (b) a population strategy which attempts to reduce
risk factor levels  in  the  whole  community,  usually  through  lifestyle  related  measures
(Rose 1985; Rose and Day 1990). The former provides higher benefits to individuals at
maximum risk. However, since such individuals are a small segment of the society, there
is no major impact on national morbidity or mortality on the country. The population
approach aims at relatively modest reductions in the risk for each individual, but the
cumulative benefits to the community are large since there are many more persons in the
mild or moderate range of risk factor elevation than there are in the highest range. The
two  strategies  are  not  mutually  exclusive  but  are  synergistically  complementary.
However,  population-based  and  lifestyle  linked  strategies  are  likely  to  prevent  the
acquisition or augmentation of NCD risk factors in transitional societies like India, while
avoiding the economic and biological costs of pharmacological risk reduction strategies
practised in the developed countries.10
Simultaneously  effective  low-cost  case-management  strategies  are  required  for
persons  who  manifest  disease.  Such  technologies  are  available  but  await  widespread
dissemination  and  application.  For  example,  oral  aspirin  administration  in  cases  of
suspected  heart  attack  saves  as  many  lives  as  the  intravenously  administered  clot
dissolving drug streptokinase (Antiplatelet Trialists Collaboration 1994).  The community
needs to be empowered, through information, to avail of such technologies, which are
both feasible for wide application and are cost-effective (Table VI).
Table VI






Cost per life saved
Aspirin 23 0 Rs. 152
Streptokinase 25 2–3 Rs. 123,560
Source: Murray and Lopez (1996).
At the population level, programmes for promotion of (a) a health promoting diet
(calories  appropriate  to  the  level  of  physical  activity;  moderation  in  the  intake  of
saturated fat, salt, and refined sugar; high intake of fresh fruit and vegetables; fish in
preference to red meat in non-vegetarian diets) and (b) adequate physical activity and
regular exercise are required. These are likely to have benefits for a wide range of NCDs,
especially CVD, diabetes, hypertension, and some cancers which are related to saturated
fat intake.
Tobacco control is a major public health imperative which will provide the largest
benefit,  for  NCD  prevention.  Tobacco-related  cancers,  CVD,  and  chronic  obstructive
airway disease are amongst the diseases which can be effectively prevented if abstinence
from tobacco and cessation of the tobacco habit are encouraged in the population. It has
been estimated that of all the teenagers who are currently smoking, half will eventually
die of tobacco related diseases (a quarter in the middle age and a quarter at an older age).11
For those who die of tobacco related illnesses in the middle age, the average loss of life-
expectancy compared to non-smokers is 20–26 years. Tobacco and AIDS represent the
most rapidly growing causes of death, the former being the foremost preventable cause of
death in the modern world (World Bank 1999). Population based control strategies are
clearly a high priority.
The success of population based interventions, addressing multiple risk factors
common  to  most  NCDs,  through  lifestyle  linked  community  programmes  has  been
demonstrated both in developed and developing countries (Puska et al. 1995; Dowsen et
al.  1995).  Such  population  strategies  require  both  ‘bottom-up’  (community  health
education  and  empowerment)  and  ‘top-down’  (legislation  and  regulation)  approaches.
Whether  it  is  food  (production,  pricing,  labelling)  or  tobacco  (production,  sale,
advertising) or physical activity (a conducive transport policy which favours urban cycle
lanes and curbs vehicular transport as well as provides facilities for leisure time exercise
in community playgrounds), active health policy measures are required alongside public
health education. An enlightened policy and an empowered community can together stall
the advance of the emerging epidemics of NCDs in India.
Presently, programmes for NCD control are non-existent or functioning at a low
level  in  India.  The  National  Cancer  Control  Programme  involves  cancer  registries  at
selected sites and strengthening of facilities for clinical care (e.g.  radiotherapy). Pilot
studies for control of CVD and diabetes have been initiated but have not impacted on
policy  and  programme  development.  Tobacco  control  is  being  accorded  greater
importance  but  awaits  early  passage  of  proposed  legislation  and  a  vigorous  public
education campaign.
Implementation
Programmes for the prevention and control of NCDs need to adopt a ‘life span’
approach,  attempt  to  reduce  risk  at  stage  of  life  through  appropriate  public  health
interventions. They also need to be variably integrated into different levels of health care12
(primary, secondary, and tertiary). The principal functions of such a programme would
be: (a) to provide information and an enabling environment for increasing awareness and
adoption of health living habits by the community; (b) early detection of persons with
risk  factors  and  cost-effective  interventions  for  reducing  risk;  (c)  early  detection  of
persons with clinical disease and cost-effective care to prevent complications; (d) acute
care, utilising low cost, high yield technologies; (e) secondary prevention to reduce, risk
of the recurrent events; and (f) rehabilitation and palliative care, in cases where disease
has resulted in complications or is incurable.
Many of these activities can be performed in primary care settings (e.g. health
education, blood pressure checks, tobacco cessation, chest pain algorithms, oral cancer
screening). Some would need to be strengthened in secondary care (e.g. management of
some  cancers,  treatment  of  left  ventricular  dysfunction).  In  settings  of  tertiary  care,
technology needs to be utilised cost-effectively to provide advanced care as per clearly
defined guidelines.









Promotion of healthy diets
(production, pricing, consumer
empowerment) including the
preparation and dissemination of
national food based dietary
guidelines
Promotion of physical activity
(planning of cities and work-sites,
community education)
Mass media campaigns – targeted
special group programmes for
community health educaiton
School based programmes for
‘Learning to Live Healthy’
Phasing out tobacco agriculture






(pollution control and promotion of
physical activity)





NCD mortality (by cause, age and
sex)
National aggregate indicators
(e.g., production and consumption
of tobacco, fruit and vegetables)
Blood lipids (total cholesterol,
HDL cholesterol)





Screening ‘Opportunistic’ screening for:
￿
  Tobacco consumption
￿








  Cervical cancer
￿









 Transient ischaemic attacks
(Contd.…)14
(Table VII Contd.)
Management Clinical algorithms for:
￿
  Acute myocardial infarction
￿
  High blood pressure
￿




  Transient ischaemic attacks
￿
  Childhood leukaemias
￿












  Other cancers
￿
  Obesity
Health Systems Integrate core components of
prevention, surveillance, screening,
and management into primary and
secondary health care
Strengthen health provider
education (learning and skills
relevant to NCD control)
Enhance the knowledge and
decision making ability of health
care managers in the elements of
NCD control
Implement essential drugs policy
for provision of NCD related drugs
Strengthen quality assurance in
NCD related health care delivery
Perform technology audits to
identify and correct inappropriate
use of expensive technologies
Strengthen the production and
distribution of cost-effective drugs
and devices for NCD care in
collaboration with industry
Research Strengthen capacity for research
relevant to NCD control through
national and international
partnerships (Implementation
research, to effectively apply
available knowledge)
Support innovation research in the
aetiology of NCDs (as relevant to
Indian population groups) and for
the identification of new
technologies which are
contextually cost-effective15
Issues in the Delivery of Chronic Care
Chronic Care and Optimisation of Available Resources
Since  the  demands  of  chronic  care  are  many  and  the  available  resources  and
restricted, efforts to optimise the use of those  resources should include the following
elements.
Identifying a Menu of Core Components for Providing an ‘Essential Package’ of Chronic
Care with Possible Extension to an ‘Optimal Package’.
A list of core (essential) and other (optional) components of chronic care needs to
be  prepared,  as  appropriate  to  the  context  of  each  state  or  (where  feasible)  of  each
district. The delivery of the ‘essential’ package must be the immediate objective of the
health care system, while the extent to which the ‘optimal’ package can be delivered is
subject to the availability of resources.
Since resource constraints are especially severe in the developing countries like
India  and  programmes  for  delivery  of  chronic  care  at  an  inception,  it  is  essential  to
identify a set of core or ‘essential’ components that constitute the minimal agenda of
chronic care. These will have to be chosen based on cost-effectiveness and impact on
population attributable risk, so as to optimise the use of available resources. In addition a
set of other ‘optimal’ components may also be identified for extending this agenda if
adequate resources become available. A suggested list is provided in Table VII.  This list
has to be customised, as appropriate to each regional context. For example, in regions
where stroke is the predominant contributor to cardiovascular mortality, algorithms for
the management of stroke may need to be included in the ‘essential’ package of chronic
care.
Integration of these Services into Various Levels of Health Care
The ' essential'  package of services must be integrated into the existing health care
infrastructure, by involving care providers, of all categories at various levels of care.16
The health care systems of most sates in India have not yet geared up to meet the
demands  of  delivering  chronic  care.  The  expanded  mandate  of  health  care,  which
involves the addition of chronic care to pre-existing services (such as maternal and child,
health, population control, and control of infectious diseases), can be delivered only when
health care providers of all categories are adequately mobilised and involved at each level
of health care. The involvement of the public sector, which provides a large part of the
care in the India, is possible only when the governments decide to adopt a programme for
integrated control of chronic diseases. The resistance of governments to commit scarce
financial and human resources to chronic care must be overcome by informed advocacy
by  health  professionals  and  community  representatives.  The  private  sector  is  usually
responsive to the needs of chronic care, since such services are considered financially
remunerative.  However,  the  imbalances  in  the  type  of  care  provided  (arising  from
frequent use of high cost, low yield technologies) must be corrected. Thus, the public
sector needs to become more responsive (to the needs of chronic care) and the private
sector should become more responsible (in the use of resources).
Clinical Practice Guidelines
The  development  of  clinical  practice  guidelines  (which  are  evidence-based,
context-specific, and resource-sensitive) and their integration into various levels of health
care will facilitate greater use of low cost-high impact interventions.
Clinical  care,  utilising  cost-effective  interventions  demonstrated  to  have  high
impact, would be a cardinal element of the global strategy for chronic care. There are
several  areas  of  chronic  care,  where  interventions  for  clinical  care  and  secondary
prevention have been  demonstrated  to  have  high  impact  at  relatively  low  costs (e.g.,
aspirin  in  the  treatment  of  heart  attacks  and  prevention  of  strokes,  the  treatment  of
childhood leukaemias, foot care, and blood pressure control in diabetics). Appropriate use
of such cost-effective clinical interventions with a potential for high impact on chronic
disease burdens should be promoted through the development, dissemination, adoption,
and  implementation  of  clinical  practice  guidelines  which  are  simple,  evidence-based,17
context-specific,  and  resource-sensitive.  Operational  research  would  be  required  to
evaluate  the  effectiveness  of  educational  interventions  to  promote  guidelines-based
clinical practice at each level of health care.
Provider Training
Education and training of health care providers, of diverse categories, would need
to be modified in order to enhance the levels of their learning and skills as relevant to
chronic disease prevention, surveillance, and management. A review of present training
programmes  should  be  undertaken  to  identify  areas  which  need  to  be  added  or
strengthened.
Current  training  programmes  for  health  care  providers  do  not  equip  them
adequately to deliver appropriate chronic care. The training of paramedics and primary
care  nurses  is  especially  deficient,  as  their  traditional  role  deals  mostly  with  ’pre-
transitional’ disorders and population control. Even physicians are not trained to follow
an  evidence-based,  guideline  directed,  algorithmic  approach  that  is  contextually
appropriate  and  cost-effective.  The  concept  of  a  team  approach,  involving  shared
responsibilities  between  the  health  workers,  nurses,  and  physicians  is  not  practically
ingrained during the training process. These deficiencies need to be addressed, through an
in-depth  review  of  the  curriculum  as  well  as  the  training  methodology,  so  as  to
appropriately strengthen the learning process in terms of chronic care delivery.
Referral Linkages and Follow-Up Systems
Efficient systems for referred care, linking primary care to other levels of provider
services (secondary and tertiary) and effective systems for subsequent follow-up care (by
primary and secondary care providers) need to be established to ensure cost-effective bi-
directional movement of patients across the health care chain.
The systems  for referral of patients  from  primary  care  for  advanced  forms  of
chronic care must be established and guidelines for such referral clearly delineated, to
ensure that referrals are both timely and necessary. Similarly, systems for reliable follow-18
up of such patients at primary/secondary levels of care (on return from secondary/tertiary
care) must be ensured, based on user friendly guidelines and algorithms developed to
facilitate such follow-up care.
Providing Patient Education and Promoting Self-Care
The constraints of limited health care provider resources may be overcome by
investing in patient education and encouraging self-care which will reduce the demands
of follow-up care.
The need for promoting participatory care through patient education and the value
of promoting self-monitoring and self-care in improving outcomes have been recently
acknowledged in  the  developed  countries.  From  the  introduction  of  patient  education
packages  for  hypertension  and  congestive  heart  failure  to  the  outstanding  success  of
diabetes  self-care,  these  practices  have  served  to  alter  the  provider  dominated
paternalistic model of care in favour of a partnership model of patient participation.
In developing country settings, the scarcity of trained health care personnel to
provide  regular  follow-up  services  for  care  of  chronic  diseases  makes  this  virtue  of
patient  education  and  self-care  a  necessity.  While  the  initial  diagnosis  and  periodic
reviews  may  involve  provider–patient  interaction,  much  of  the  regular  care  may  be
undertaken by the patient (and/or family members). This will reduce the periodicity of the
required follow-up visits. While this requires investment in educational programmes, it
will prove cost-effective in the long term management of chronic diseases.
Essential Drugs and Technology Needs
Any  programme  for  providing  chronic  care  must  ensure  the  availability  of
essential drugs at affordable prices and meet the technology needs of managing a variety
of chronic diseases.19
The agenda of chronic care would become infructuous, if essential drugs are not
available to needy consumers at affordable prices. The advent of compulsory ’product
patenting’ under the WTO regime will restrict the scope of local production. However,
countries like India and Brazil have used the practice of ’process patenting’ to build self-
sufficiency in the production of many drugs, including most of the essential drugs. These
are available, as generic drugs, at relatively low cost. The Indian pharmaceutical industry
needs to be encouraged to invest more in research and development to produce new drugs
for the local market.
Non-availability of technology, for deployment at various levels of health care,
may be a major threat to the delivery of chronic care. Technology required for providing
the ‘essential’ package of care at primary level would be easier to provide than more
advanced  technologies  for  secondary  and  tertiary  care.  South–South  cooperation  for
technology  exchange,  international  assistance  for  subsidising  essential  technology
acquisition,  and  guideline  based  use  of  available  technology  will  help  developing
countries  like  India  to  overcome  the  technology  barrier.  Well-conducted  research
involving the economic evaluation of various health care technologies will aid decisions
regarding the nature of technologies that are most cost-effective at each level of health
care and the extent to which they should be deployed. Capacity for such research in
health economics must be quickly established and integrated into the planning process in
Health Ministries and other health care financing agencies.
Situational Analysis
Estimates  of  existing  and  required  capacity  for  delivering  chronic  care  to
communities must guide the process of planning. Qualitative and quantitative research
methods will help to identify key indicators for such a situational analysis.
While planning for the delivery of chronic care to a community in any region, it
would be essential to be cognisant of the capacity which exists within that community to
meet current chronic care needs, in terms of policy, programmes, and infrastructure. The20
anticipated  growth  in  ‘capacity’  (defined  as  a  composite  whole,  comprising  of  these
components), vis-à-vis the projected rise in the burden of chronic diseases, would also
need to be appraised. The suggested components of such a ‘situational analysis’ study are
listed in Table VIII.
Such  an  assessment  would  involve  a  mixture  of  qualitative  and  quantitative
research  methods  to  tap  a  variety  of  stakeholder  perspectives  and  map  the  status  of
diverse indicators of capacity (from health beliefs of the community to the availability of
essential drugs at affordable prices).  Any planning process for providing chronic care
must be based on such a situational analysis of the required and available capacity.
Table VIII
Assessment of National Capacity: Questions for Situational Analysis
1.  What is the current capacity, within a defined community setting, for community participation
in programmes related to the prevention and control of NCDs?
(health  beliefs;  access  to  information;  networking  within  the  community;  partnerships  with
external  agencies;  availability,  affordability.  Acceptability  of,  and  access  to  promotive
preventive, and therapeutic health care)
2.  What  is  the  current  capacity,  within  the  provincial/regional  health  care  delivery  system,  to
provide promotive, preventive, and therapeutic health care, as relevant to prevention and control
of NCDs in that community?
(currently  operational  programmes:  content,  resources,  outreach;  health  care  providers:
numbers,  training,  skills,  motivation,  time;  resources  for  essential  care:  community  health
education,  essential  drugs,  equipment,  guidelines,  patient  education;  referral  linkages  and
follow-up services; surveillance systems)
3.  What is the current capacity, within the provincial and national policy framework (regulation,
legislation, taxation), to provide a supportive environment for people, patients, and providers to
adopt practices conducive to the prevention and control of NCDs in the community?
(tobacco control; food and nutrition; education; drug production, pricing and supply; resource
allocation; urban planning; health care financing; media)
4.  What are the critical deficiencies in the capacity for and major barriers to the prevention and
control of NCDs, in the perception of (a) community representatives, (b) health care providers
(c) health administrators and (d) policymakers? What are the prioritised solutions recommended
by each of these groups?
5.  What is the required augmentation of capacity that is considered (a) desirable and (b) feasible,
by policymakers, to meet the projected rise in needs for the prevention and control of NCDs
over the next twenty years?
Note:  Adapted from the project protocol of Initiative for Cardiovascular Health in the Developing
Countries (www.ichealth.org)21
Customization
Different geographical regions have  a differing mix  of  chronic  diseases. Even
within  a  country,  the  magnitude  of  different  chronic  diseases  will  vary  across  social
classes, gender and age groups. Within the broad framework of integrated chronic care,
these varied needs have to be addressed through an appropriate mix of interventions,
which are most relevant and cost-effective.
While the general needs of chronic care are likely to be similar for most regions in
India, the specific mix of prioritised services would differ from region to region. These
variations would be determined by the current state of health transition, projected pace of
the chronic disease epidemics,  geographic epidemiology of disease patterns, status  of
health services, resource scenario, and prioritisation within the health sector. Since there
are also likely to be disparities related to socio-economic status, gender, and age resulting
in a diversity of health states as well as variable access to health care, provisions for
chronic care would also need to customised within a country. This applies, for example,
to guidelines and algorithms for detection and management of risk factors and disease
states.
The  interventions  proposed  for  the  prevention  and  management  of  chronic
diseases  should  be  based  on  demonstrated  efficacy  as  well  as  likely  financial  and
operational feasibility of integration into various levels of health care. Cost-effectiveness
of  specific  interventions  will,  however,  need  to  be  estimated  or  modelled  for  each
country, based on country-specific estimates of costs and impact. Ideally, such a cost-
effectiveness analysis should be generalised, employing a sectoral approach, and seek to
evaluate a wide range of interventions and resource allocation options.
Influencing Policymakers and Health System Managers
Concerted efforts must be made to enhance the knowledge of policy-makers and
health system managers, at various levels, about the potential impact of cost-effective22
chronic  care  interventions  and  the  high  costs  of  ’missed  opportunities’  so  that  they
become motivated agents for improving the delivery of chronic care.
There  are  many  ’missed  opportunities’  in  clinical  practice  which  cumulatively
contribute to high burdens of chronic disease through errors of omission. The failure to
administer aspirin to a case of suspected acute myocardial infarction results in loss of an
opportunity to reduce early mortality by 23 per cent. Similarly, the neglect to offer advice
regarding smoking cessation to diabetic or hypertensive patients results in a high burden
of avoidable vascular deaths. Sensitising the policy-makers and health care managers to
the health costs of such missed opportunities will ensure that adequate attention is paid to
such aspects while planning and monitoring the delivery of chronic care.
Overcoming the Barriers
The  operational  priorities  listed  above  face  several  barriers  for  effective
implementation, in the context of the developing countries. These include: short supply
and  maldistribution  of  trained  health  care  providers  (with  a  disproportionately  large
selective urban clustering of physicians  and massive shortage of trained  paramedics);
inadequate knowledge and skills for providing chronic care, in the currently deployed
primary care providers; ill-defined roles of the public, private, and voluntary sectors in
providing chronic care and inadequate purchasing power among consumers for accessing
chronic care. The following strategies are suggested as potential methods of overcoming
those barriers.
Community Participation
Empowerment  of  the  community,  through  effectively  communicated  health
information  and  support  of  enabling  social  environments  will  allow  individuals  to
perform many tasks related to chronic care, ranging from self-care to assisted care of
others.23
The needs of integrating promotive and preventive care, early detection of risk
factors, and disease, as well as certain types of emergency care into the ambit of primary
health  care  can  only  be  addressed  effectively  when  the  community  is  adequately
mobilised to participate in these activities. This will be in consonance with the currently
recommended models of development which emphasise devolution of decision making
power to communities, with decentralisation of programme planning and implementation.
By empowering communities with information and skills, a large mass of individuals can
be  energised  to  take  on  functions  traditionally  assigned  to  health  care  providers  in  a
public health system. While a reasonable level of financial and technical resources and
referral support would have to be provided by the public health system, the outreach of
services  would  be  greatly  enhanced  for  the  level  of  resources  invested.  From  self-
examination for oral and breast cancer to emergency care of acute cardiac events, an
informed individual can perform several functions related to chronic care. Appropriate
self-referrals (e.g. for blood pressure, diabetes, or cancer screening) are also promoted by
such  an  approach.  Health  education  would  also  facilitate  awareness  and  adoption  of
health promoting behaviours which would prevent disease and reduce disability.  While
low levels of literacy are often perceived to be a barrier, the wide outreach of the audio-
visual mass media will help effective communication with the community.
The large population size of  India  has  traditionally  been  viewed  as  the major
constraints  to  the  delivery  of  adequate  health  care.  By  facilitating  community
participation, these  very  numbers  could  be  converted  into  abundant  resources  for  the
delivery of essential services related to chronic care. The preservation, to a large extent,
of an extended family structure and strong social support systems within the community,
should substantially enable assistance of self-care or delivery of chronic care through the
families as well as other social networks. This resource must be adequately utilised to
reduce dependence on health care providers in the public or private delivery systems.
From  the  management  of  diabetes  and  high  blood  pressure  to  community  based
management of mental illnesses, this would reduce the demands on follow-up services
and institutional care.24
Broadening the Base of Care Providers in Primary Health Care
The  use  of  trained  public  health  nurses,  community  health  workers,  and
practitioners  of  complementary  systems  of  medicine  to  deliver  some  of  the  services
currently assigned to physician care providers in primary health care will extend outreach
at a lower cost.
Since  the  existing  strength  of  physician  care  providers  is  low  or  grossly
maldistributed with selective urban clustering, there is a need to provide essential chronic
health care to underserved populations, especially those in rural areas. This may be done
through the development of a cadre of Community Health Workers (CHWs) who are
recruited from within the communities to be served and trained to deliver those essential
services.  Since they are selected by the community from its members and the training
period is shorter than for physician care providers, the services provided by them are
likely to be sustainable and less expensive. While existing public health care systems do
employ multipurpose health workers (MPWs), their current numbers and workload do not
make  them  easily  available  for  delivering  services  related  to  chronic  care.  The
recruitment, training, and deployment of CHWs will help in providing chronic care by
enhancing the number of trained paramedics with a clear mandate for chronic care. While
CHWs may need to perform other duties as well, their work schedule should be framed to
facilitate delivery of chronic care as an essential element. The feasibility of training such
health  care  auxiliaries  in  the  prevention  and  early  detection  of  oral  cancer  and  pre-
cancerous lesions has been demonstrated by studies conducted in parts of India and Sri
Lanka (Shankaranarayanan 1997).
Similarly, the development of a cadre of public health nurses will help to increase
the  number  of  primary  health  care  providers  equipped  with  the  skills  for  delivering
essential  chronic  care  (such  as  counselling  on  health  behaviours,  detection  and
management of high blood pressure and diabetes, screening for common cancers, initial
management of chest pain syndromes suggestive of acute coronary events, management
of acute asthmatic attacks, etc.)25
The  large  number  of  care  providers  who  serve  as  practitioners  of  alternate
(complementary)  systems  of  medicine  also  need  to  be  recruited  into  the  delivery  of
chronic care on a country specific context. Their ready availability and widespread appeal
to many underserved communities will make them valuable resources, provided they are
equipped with the information and skills relevant to chronic care.
Training and Reorientation of Existing Primary Health Care Providers for Delivering
Chronic Care Services
Currently deployed primary health care providers, of different categories, need to
be  retrained,  along  with  restructuring  of  their  work  schedules,  and  supported  by
guidelines to deliver essential chronic care at that level.
The  existing  personnel  in  primary  health  care  service  (physicians,  nurses,
paramedics) need to be retrained, to equip them with the knowledge and skills required
for  delivering  the  essential  elements  of  chronic  care.  At  the  same  time,  time-motion
studies  need  to  be  conducted  to  examine  how  their  current  work  schedules  can  be
modified to accept this expanded mandate of health care, through redefinition of their
assigned work.
Preparation of guidelines and management algorithms is essential to assist such
retraining and future work. These need to be developed for each category of health care
providers and integrated effectively into primary care practice. Professional associations
must  be  extensively  engaged  in  this  effort,  so  that  the  private  care  providers  are
adequately addressed, in addition to government employees. Health non-governmental
organisations (NGOs) too can play a valuable role in creating educational resources as
well as facilitating the training of various categories of care providers.
Promoting Public, Private, and Voluntary Sector Mix and Quality of Care26
Delivery of chronic care in primary and secondary health care settings requires a
partnership  of  public,  private,  and  voluntary  sectors,  with  definition  of  standards,
adoption of guidelines, and monitoring of practice patterns to ensure quality of care.
While India has traditionally depended on public health systems for provision of
primary care, private care providers have become increasingly important contributors to
the delivery of such services. The role of the private sector has also rapidly grown in
secondary and tertiary health care services. In a number of states, the voluntary sector
(represented by health NGOs) has also been contributing to primary and secondary care
through direct services, apart from playing the watchdog role. In the state of Karnataka,
for example, a number of ‘sick’ primary health care centres have been handed over by the
government to a health NGO for operation.
Ensuring the quality of care and the definition of standards are issues relevant to
all three sectors. In many countries the poor quality of care of public services leads to the
reluctance of the population to use those services,  inducing  underutilisation  of costly
resources. The inability to deliver cost-effective care of acceptable quality may arise due
to a variety of constraints (financial, motivational, and organisational). These need to be
addressed, as relevant to each sector, so that the desired levels of quality can be attained.
Standards need to be defined, based on expert consensus, and adopted through a process
involving  wide-ranging  consultations  among  different  categories  of  stakeholders.  The
development and adoption of guidelines as well as periodic profiling of practice patterns
along with technology audits would help to ensure reliable delivery of rational health
care.
Health Care Financing
A mix of public sector provision of free health care, social insurance, and private
insurance would have to be evolved to enable universal access to essential chronic care.27
The ’user pays’ principle is frequently advocated as a component of health care
reforms. The services related to chronic care are often excluded from the package of
’essential  services’  which  are  deemed  the  responsibility  of  the  public  sector.  This
frequently  imposes  great  burdens  on  the  consumer,  especially  in  developing  country
settings. Some of the services (like ’opportunistic’ screening for oral and cervical cancers
and hypertension and ’targeted’ screening for diabetes) may have to be provided as part of
the public health sector’s ’essential’ package of services. Group insurance schemes may be
employed in the organised sector. Differentiated services may be offered, so that those
willing to pay can avail of a higher category of services or better facilities, beyond a basic
minimum of essential services which should be available to all.
The public sector should not disengage completely from chronic care. Apart from
the fact that public sector supply of good medical services can exert a pressure on the
high costs of private sector medical services to scale down, the public sector also fulfills a
training and research mandate far beyond the capacity or the aptitude of the private sector
in  the  developing  countries.  A  system  of  social  insurance  for  the  economically
disadvantaged sections would have to be provided, with private insurance for the more
affluent sections. This mix would have to be customised for each national context.
Innovative methods for financing health care need evaluation. With decentralised
health care, local taxes may be levied by community organisations responsible for health
care (with matching grants from the state, as an incentive). Rural micro-credits also may
help enhance purchasing power, without imposing severe financial burdens.
Prioritisation of Interventions
Of the several operational components of chronic care outlined above, a process
of prioritisation must sequentially select ’essential’ elements for early implementation and
’optimal’ elements for later implementation (Table VII).  Prevention and control of high
blood  pressure  and  tobacco  consumption  are  high  priorities,  because  of  their  high
contribution  to  the  global  burden  of  disease  as  well  as  their  relationship  to  multiple28
chronic diseases. High blood pressure, for example, is a major risk factor for CHD and
stroke and its control has been shown to be a major determinant of improved survival in
diabetics. Tobacco is a prime contributor to global mortality, through the causation of
CHD,  many  cancers,  and  chronic  obstructive  pulmonary  disease.  Similarly,  clinical
conditions such as acute myocardial infarction, congestive heart failure, and childhood
leukaemias are associated with high mortality but also have available interventions of
high  impact  for  improving  survival.  These  need  to  be  preferentially  promoted  to
substantially reduce the burden of chronic disease.
While planning the organisation of health services, the goal should be to shift the
centre of gravity of chronic care delivery progressively towards the base of the health
care  pyramid.  By  strengthening  the  capacity  for  care  by  self,  family,  community,
paramedic,  or  traditional  healer  and  by  encouraging  guidelines  based  practice  and  a
rational  referral-follow-up  pattern  which  obviates  the  need  for  frequent  revisits  to
secondary  and  tertiary  care  providers,  the  responsibility  for  delivering  chronic  care
devolves downwards closer to the community and away from the more expensive and
less accessible higher health care stations. Only such a shift can ensure a sustainable
system of chronic care in India, with the promise of extended coverage and containment
of costs.29
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